Atlas Trials

Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer

Clinical trial NCT03058939 · WITHDRAWN

Trial details

NCT number
NCT03058939
Sponsor
University of Chicago
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerBreast Cancer Stage IIBreast Cancer Stage III
Start date
2018-11-01
Primary completion
2019-04-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.